Puma Biotechnology Dividends
PBYI Stock | USD 3.58 0.59 19.73% |
The Puma Biotechnology's current Dividend Paid And Capex Coverage Ratio is estimated to increase to 729.71. Puma Biotechnology's past performance could be the main factor of why investors trade Puma Biotechnology stock today. Investors should clearly understand every aspect of the Puma Biotechnology dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Puma Biotechnology's dividend schedule and payout information. Puma Biotechnology dividends can also provide a clue to the current valuation of Puma Biotechnology.
Last Reported | Projected for Next Year | ||
Dividend Paid And Capex Coverage Ratio | 694.96 | 729.71 |
Puma |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Puma Biotechnology must own a stock before its ex-dividend date to receive its next dividend.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Puma Biotechnology. If investors know Puma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Puma Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.417 | Earnings Share 0.47 | Revenue Per Share | Quarterly Revenue Growth 0.435 | Return On Assets |
The market value of Puma Biotechnology is measured differently than its book value, which is the value of Puma that is recorded on the company's balance sheet. Investors also form their own opinion of Puma Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Puma Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Puma Biotechnology's market value can be influenced by many factors that don't directly affect Puma Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Puma Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Puma Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Puma Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.